ABBV-0805 Reduces Alpha-synuclein Clumping in Mice
ABBV-0805, AbbVie’s experimental antibody-based therapy for Parkinson’s disease, selectively binds to toxic clumps of the alpha-synuclein protein —…
Articles by Marta Figueiredo, PhD
Deaths From Parkinson’s Rising in US Over Two Decades, Study Reports
The death rate from Parkinson’s disease in the U.S. has gradually and significantly increased — by 63% — over…
DBS in Early Parkinson’s Found to Lower Medication Use, Costs
Deep brain stimulation (DBS) in adults with early Parkinson’s reduces disease-specific medication use and provides significant cost savings, for…
CNM-Au8 Improved Brain’s Energetic Profile in Parkinson’s Patients
CNM-Au8, an experimental oral treatment by Clene Nanomedicine, was safe and led to improvements in the brain’s energetic…
Sleep Disorder Tied to Faster Disease Progression
Early Parkinson’s patients with rapid eye movement sleep behavior disorder (RBD) have more severe symptoms and show a faster disease…
AI Analyzes Facial Expressions in Videos to Help Detect Parkinson’s
An artificial intelligence (AI) tool was able to distinguish, with great accuracy, Parkinson’s patients from healthy peers by analyzing…
3D Brain Organoids Capture Hallmarks ‘Only Seen in Patients’
Researchers developed “mini-brains” — midbrain-like organoids — that recapitulate for a first time two key Parkinson’s hallmarks in that organ:…
$1.8M Earmarked for Cutting-edge Parkinson’s Research
The American Parkinson Disease Association (APDA) has awarded $1.85 million to research projects focused on innovative tools and strategies to advance…
Preexisting Bipolar Disorder Worsens Parkinson’s Problems
A previous diagnosis of bipolar disorder negatively affects the course of Parkinson’s disease, and is associated with greater neuropsychiatric…
Sweet Marjoram Tea May Lessen Non-motor Symptoms
Daily consumption of sweet marjoram tea, in addition to standard antiparkinsonian medication, may help reduce non-motor symptoms and depression in…